MedTrace Logo

Clinical Tumor Anemia Registry (TAR)

NCT01795690 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1018

Last updated 2016-02-29

No results posted yet for this study

Summary

The purpose of this registry is to record information of routine treatment of anemia in cancer patients in Germany. An overview of the current treatment of anemia in German outpatient centers and hospitals will be provided. Primary outcome parameters, e.g. improvement in hemoglobin levels and changes in QoL, as well as patient characteristics of different treatments will be analyzed.

Conditions

Sponsors & Collaborators

  • ASORS (Arbeitsgemeinschaft Supportive Maßnahmen in der Onkologie, Rehabilitation und Sozialmedizin der Deutschen Krebsgesellschaft)

    collaborator UNKNOWN

  • iOMEDICO AG

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-12-31
Primary Completion
2013-09-30
Completion
2016-02-29

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01795690 on ClinicalTrials.gov